TRPC3 properties of a native constitutively active Ca2+-permeable cation channel in rabbit ear artery myocytes.
Previously we have described a constitutively active, Ca2+-permeable, non-selective cation channel in freshly dispersed rabbit ear artery myocytes which has similar properties to some of the canonical transient receptor potential (TRPC) channel proteins. In the present work we have compared the properties of constitutive channel activity with known properties of TRPC proteins by investigating the effect of selective anti-TRPC antibodies and pharmacological agents on whole-cell and single cation channel activity. Bath application of anti-TRPC3 antibodies markedly reduced channel activity in inside-out patches and also produced a pronounced reduction of both current amplitude and variance of constitutively active whole-cell cation currents whereas anti-TRPC1/4/5/6/7 antibodies had no effect on channel activity. In the presence of antigenic peptide, anti-TRPC3 antibodies had no effect on whole-cell or single cation channel activity. Bath application of flufenamic acid, Gd3+, La3+ and Ca2+ inhibited spontaneous channel activity in outside-out patches with IC50 values of 6.8 microm, 25 nm, 1.5 microm and 0.124 mm, respectively, which are similar values to those against TRPC3 proteins. Immunocytochemical studies combined with confocal microscopy showed expression of TRPC3 proteins in ear artery myocytes, and these were predominately distributed at, or close to, the plasma membrane. These data provide strong evidence that native constitutively active cation channels in rabbit ear artery myocytes have similar properties to TRPC3 channel proteins and indicate that these proteins may have an important role in mediating this conductance.
Albert
A P
AP
Ion Channels and Cell Signalling Research Centre, Division of Basic Medical Sciences, St George's, University of London, Cranmer Terrace, London SW17 ORE, UK. aalbert@sgul.ac.uk
Pucovsky
V
V
Prestwich
S A
SA
Large
W A
WA
D000818:Animals; D001158:Arteries / Q000502:physiology*; D015220:Calcium Channels / Q000378:metabolism*; D020013:Calcium Signaling; D002412:Cations; D004423:Ear / Q000502:physiology; D005439:Flufenamic Acid; D007150:Immunohistochemistry; D015640:Ion Channel Gating / Q000502:physiology*; D007473:Ion Channels / Q000502:physiology; D008564:Membrane Potentials / Q000502:physiology*; D018613:Microscopy, Confocal; D032389:Myocytes, Smooth Muscle / Q000378:metabolism / Q000502:physiology*; D011817:Rabbits; D050052:TRPC Cation Channels / Q000378:metabolism / Q000502:physiology*
D015220:Calcium Channels; D002412:Cations; D007473:Ion Channels; D050052:TRPC Cation Channels; C104603:TRPC3 cation channel; D005439:Flufenamic Acid